These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 7496197)

  • 41. Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001.
    Pépin J; Mpia B
    Emerg Infect Dis; 2005 Jun; 11(6):921-7. PubMed ID: 15963288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Killer coma: the evolving story of sleeping sickness treatment.
    Lancet; 2010 Jan; 375(9709):93. PubMed ID: 20109869
    [No Abstract]   [Full Text] [Related]  

  • 43. Potential new drugs for human African trypanosomiasis: some progress at last.
    Barrett MP
    Curr Opin Infect Dis; 2010 Dec; 23(6):603-8. PubMed ID: 20844428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Rhodesian sleeping sickness in Kenya.
    Wellde BT; Chumo DA; Reardon MJ; Abinya A; Wanyama L; Dola S; Mbwabi D; Smith DH; Siongok TA
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():99-109. PubMed ID: 2619399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda.
    Politi C; Carrín G; Evans D; Kuzoe FA; Cattand PD
    Health Econ; 1995; 4(4):273-87. PubMed ID: 8528430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Existing chemotherapy and its limitations.
    Gutteridge WE
    Br Med Bull; 1985 Apr; 41(2):162-8. PubMed ID: 3161577
    [No Abstract]   [Full Text] [Related]  

  • 47. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
    Simarro PP; Asumu PN
    Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
    [No Abstract]   [Full Text] [Related]  

  • 48. Trypanosoma brucei and T. vivax: salicylhydroxamic acid and glycerol treatment of acute and chronically infected rats.
    van der Meer C; Versluijs-Broers JA
    Exp Parasitol; 1986 Aug; 62(1):98-113. PubMed ID: 3720904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda.
    Kansiime F; Adibaku S; Wamboga C; Idi F; Kato CD; Yamuah L; Vaillant M; Kioy D; Olliaro P; Matovu E
    Parasit Vectors; 2018 Feb; 11(1):105. PubMed ID: 29471865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine.
    Steverding D; Rushworth SA
    Exp Parasitol; 2017 Jul; 178():45-50. PubMed ID: 28552794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental infection of goats with Trypanosoma brucei ssp. and effects of treatment with suramin and Mel-B.
    Wellde BT; Reardon MJ; Chumo DA; Muriithi RM; Towett S; Mwangi J
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():161-9. PubMed ID: 2619390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment perspectives for human African trypanosomiasis.
    Bouteille B; Oukem O; Bisser S; Dumas M
    Fundam Clin Pharmacol; 2003 Apr; 17(2):171-81. PubMed ID: 12667227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemotherapy of African trypanosomiasis.
    Williamson J
    Trop Dis Bull; 1976 Jul; 73(7):531-42. PubMed ID: 135387
    [No Abstract]   [Full Text] [Related]  

  • 54. Human African Trypanosomiasis in a Spanish traveler returning from Tanzania.
    Gómez-Junyent J; Pinazo MJ; Castro P; Fernández S; Mas J; Chaguaceda C; Pellicé M; Gascón J; Muñoz J
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005324. PubMed ID: 28358876
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of late stage rhodesiense trypanosomiasis using suramin and eflornithine: report of six cases.
    Clerinx J; Taelman H; Bogaerts J; Vervoort T
    Trans R Soc Trop Med Hyg; 1998; 92(4):449-50. PubMed ID: 9850406
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of human African trypanosomiasis.
    Dumas M; Bouteille B
    Bull World Health Organ; 2000; 78(12):1474. PubMed ID: 11196500
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination of eflornithine and melarsoprol for melarsoprol-resistant Gambian trypanosomiasis.
    Mpia B; Pépin J
    Trop Med Int Health; 2002 Sep; 7(9):775-9. PubMed ID: 12225509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin.
    Clarkson AB; Bienen EJ; Bacchi CJ; McCann PP; Nathan HC; Hutner SH; Sjoerdsma A
    Am J Trop Med Hyg; 1984 Nov; 33(6):1073-7. PubMed ID: 6439061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug sensitivity of pleomorphic Trypanosoma rhodesiense.
    Williamson J
    Trans R Soc Trop Med Hyg; 1983; 77(2):192-3. PubMed ID: 6223414
    [No Abstract]   [Full Text] [Related]  

  • 60. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis.
    Simarro PP; Franco J; Diarra A; Postigo JA; Jannin J
    Parasitology; 2012 Jun; 139(7):842-6. PubMed ID: 22309684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.